Financial statements Bls Pharma W Likwidacji
Balance sheet data of BLS PHARMA W LIKWIDACJI
|
Year
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 1 491 507,70 | 1 266 812,25 | 975 604,82 | 563 154,94 |
| A. Fixed assets | 215 981,61 | 186 711,29 | 180 382,13 | 0,00 |
| B. Current assets | 1 275 526,09 | 1 080 100,96 | 795 222,69 | 563 154,94 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | - | 0,00 |
| Total liabilities | 1 491 507,70 | 1 266 812,25 | 975 604,82 | 563 154,94 |
| A. Equity | 1 118 661,63 | 933 664,77 | 757 010,83 | 556 143,94 |
| B. Liabilities and provisions for liabilities | 372 846,07 | 333 147,48 | 218 593,99 | 7 011,00 |
| I. Long-term liabilities | 131 069,60 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 241 776,47 | 333 147,48 | 218 593,99 | 7 011,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.